中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
机构
采集方式
内容类型
发表日期
学科主题
筛选

浏览/检索结果: 共30条,第1-10条 帮助

条数/页: 排序方式:
Discovery of a potent and selective covalent threonine tyrosine kinase (TTK) inhibitor 期刊论文  OAI收割
BIOORGANIC CHEMISTRY, 2024, 卷号: 143, 页码: 16
作者:  
Sun, Yaoliang;  Chen, Zhiwen;  Liu, Guobin;  Chen, Xiaoai;  Shi, Zihan
  |  收藏  |  浏览/下载:8/0  |  提交时间:2024/03/25
Covalent Binding Mechanism of Furmonertinib and Osimertinib With Human Serum AlbuminS 期刊论文  OAI收割
DRUG METABOLISM AND DISPOSITION, 2023, 卷号: 51, 期号: 1, 页码: 8-16
作者:  
Wu, Yali;  Chen, Lili;  Chen, Jian;  Xue, Hao;  He, Qingfeng
  |  收藏  |  浏览/下载:1/0  |  提交时间:2024/03/27
Triazine-Based Covalent DNA-Encoded Libraries for Discovery of Covalent Inhibitors of Target Proteins 期刊论文  OAI收割
ACS MEDICINAL CHEMISTRY LETTERS, 2022, 页码: 8
作者:  
Li, Linjie;  Su, Mingbo;  Lu, Weiwei;  Song, Hongzhi;  Liu, Jiaxiang
  |  收藏  |  浏览/下载:20/0  |  提交时间:2022/09/30
Discovery of Pteridine-7(8H)-one Derivatives as Potent and Selective Inhibitors of Bruton's Tyrosine Kinase (BTK) 期刊论文  OAI收割
JOURNAL OF MEDICINAL CHEMISTRY, 2022, 卷号: 65, 期号: 3, 页码: 2694-2709
作者:  
Dou, Dou;  Diao, Yanyan;  Sha, Wenjie;  Su, Rongrong;  Tong, Linjiang
  |  收藏  |  浏览/下载:24/0  |  提交时间:2022/08/16
Discover Novel Covalent Inhibitors Targeting FLT3 through Hybrid Virtual Screening Strategy 期刊论文  OAI收割
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2021, 卷号: 44, 期号: 12, 页码: 1872-1877
作者:  
Hu, Shengquan;  Liu, Jing;  Chen, Sikang;  Gao, Jian;  Zhou, Yubo
  |  收藏  |  浏览/下载:21/0  |  提交时间:2022/06/15
Discovery of a potent, selective, and covalent ZAP-70 kinase inhibitor 期刊论文  OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 219, 页码: 12
作者:  
Rao, Danni;  Li, Heng;  Ren, Xuelian;  Sun, Yaoliang;  Wen, Cuiyun
  |  收藏  |  浏览/下载:26/0  |  提交时间:2021/08/17
Design, synthesis and biological evaluation of pyrazolo[3,4-d]pyridazinone derivatives as covalent FGFR inhibitors 期刊论文  OAI收割
ACTA PHARMACEUTICA SINICA B, 2021, 卷号: 11, 期号: 3, 页码: 781-794
作者:  
Wu, Xiaowei;  Dai, Mengdi;  Cui, Rongrong;  Wang, Yulan;  Li, Chunpu
  |  收藏  |  浏览/下载:35/0  |  提交时间:2021/05/24
p Metabolite Identification in the Preclinical and Clinical Phase of Drug Development 期刊论文  OAI收割
CURRENT DRUG METABOLISM, 2021, 卷号: 22, 期号: 11, 页码: 838-857
作者:  
Wu, Yali;  Pan, Lulu;  Chen, Zhendong;  Zheng, Yuandong;  Diao, Xingxing
  |  收藏  |  浏览/下载:16/0  |  提交时间:2022/06/15
Characterization of covalent binding of tyrosine kinase inhibitors to plasma proteins 期刊论文  OAI收割
DRUG METABOLISM AND PHARMACOKINETICS, 2020, 卷号: 35, 期号: 5, 页码: 456-465
作者:  
Liu, Xiaoyun;  Feng, Dan;  Zheng, Mingyue;  Cui, Yongmei;  Zhong, Dafang
  |  收藏  |  浏览/下载:29/0  |  提交时间:2020/12/21
Design, synthesis and biological study of potent and covalent HER-2 tyrosine kinase inhibitors with low cytotoxicity in vitro 期刊论文  OAI收割
CHEMICAL PAPERS, 2019, 卷号: 73, 期号: 6, 页码: 1333-1345
作者:  
Jin, Shuyu;  Sun, Xiuyun;  Liu, Dan;  Xie, Hua;  Rao, Yu
  |  收藏  |  浏览/下载:11/0  |  提交时间:2020/07/01